Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
HiFiBiO Therapeutics
BioNTech SE
N.N. Petrov National Medical Research Center of Oncology
Slovak Academy of Sciences
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
UNICANCER
Indiana University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
OHSU Knight Cancer Institute
City of Hope Medical Center
Rutgers, The State University of New Jersey
Dana-Farber Cancer Institute
UNICANCER
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Barbara Ann Karmanos Cancer Institute
Northwestern University
Memorial Sloan Kettering Cancer Center
Indiana University
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Duke University
University of Southampton
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center